Influenza Antiviral Expenditures and Outpatient Prescriptions in the United States, 2003-2012-Reference-Cited by-同舟云学术

Influenza Antiviral Expenditures and Outpatient Prescriptions in the United States, 2003-2012

Published:2015-11 Issue:11 Volume:35 Page:991-997
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Suda Katie J.¹,Hunkler Robert J.²,Matusiak Linda M.³,Schumock Glen T.⁴

Affiliation:

1. Center of Innovation of Complex Chronic Healthcare; Department of Veterans Affairs and Department of Pharmacy Systems, Outcomes, and Policy; University of Illinois at Chicago; Hines Illinois

2. Professional Relations; IMS Health; Fountain Hills Arizona

3. Professional Relations; IMS Health; Collegeville Pennsylvania

4. Department of Pharmacy Systems, Outcomes, and Policy; University of Illinois at Chicago; Chicago Illinois

Publisher

Wiley

Subject

Pharmacology (medical)

Reference27 articles.

1. Estimates of deaths associated with seasonal influenza - United States, 1976-2007;Centers for Disease Control and Prevention (CDC);MMWR Morb Mortal Wkly Rep,2010

2. Influenza-associated hospitalizations in the United States;Thompson;JAMA,2004

3. Multisystem failure: the story of anti-influenza drugs;Jefferson;BMJ,2014

4. Genentech USA, Inc Tamiflu [package insert] South San Francisco, CA 2011

5. GlaxoSmithKlline Relenza [package insert] Research Triangle Park, NC 2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Public Health Impact of Paxlovid as Treatment for COVID-19, United States;Emerging Infectious Diseases;2024-02

2. Determination of Umifenovir and Its Metabolites by High-Performance Liquid Chromatography with Combined Mass Spectrometric Detection;Journal of Analytical Chemistry;2023-09

3. The public health impact of Paxlovid COVID-19 treatment in the United States;2023-06-19

4. Timely Antiviral Administration During an Influenza Pandemic: Key Components;American Journal of Public Health;2018-09

5. Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza;Emerging Infectious Diseases;2016-06